Stark Novus director fund buys 9,000 NRDE shares
Stark Novus Financial Inc. (NRDE) had one insider-related entity, ESOPUS CREEK VALUE SERIES FUND LP - SERIES A (a director), report purchasing 9,000 shares of Common Stock at $1.83 per share on August 25, 2026.
Rhea-AI Filing Summary
Stark Novus Financial Inc. (NRDE) had one insider-related entity, ESOPUS CREEK VALUE SERIES FUND LP - SERIES A (a director), report purchasing 9,000 shares of Common Stock at $1.83 per share on August 25, 2026. Following this open-market or private transaction, the reporting entity holds 772,000 shares directly, subject to pecuniary-interest limitations.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 9,000 shares
Net Buy
1 txn
Insider
ESOPUS CREEK VALUE SERIES FUND LP - SERIES A
Role
Director
Bought
9,000 shs ($16K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, par value $0.0001 F1 | 9,000 | $1.83 | $16K |
Holdings After Transaction:
Common Stock, par value $0.0001 — 772,000 shares (Direct)
Footnotes (1)
- F1. The reporting person disclaims ownership of these securities except to the extent of the reporting person's pecuniary interest therein.
Key Figures
Shares purchased: 9,000 shares
Purchase price per share: $1.83 per share
Shares held after transaction: 772,000 shares
+2 more
5 metrics
Shares purchased
9,000 shares
Common Stock transaction on August 25, 2026
Purchase price per share
$1.83 per share
Common Stock, par value $0.0001
Shares held after transaction
772,000 shares
Direct holdings of ESOPUS CREEK VALUE SERIES FUND LP - SERIES A after purchase
Number of buy transactions
1 transaction
Form 4 transaction summary for August 25, 2026
Net shares bought
9,000 shares
Net buy-sell direction reported as net-buy
Key Terms
beneficial ownership, pecuniary interest, Rule 10b5-1, open market or private transaction
4 terms
beneficial ownership financial
"disclaims beneficial ownership of the securities covered by this statement"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of the pecuniary interest of such person"
Rule 10b5-1 regulatory
"aff_10b5_one"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open market or private transaction financial
"Purchase in open market or private transaction"
FAQ
What insider transaction was reported for NRDE in this Form 4?
A director-affiliated entity, ESOPUS CREEK VALUE SERIES FUND LP - SERIES A, reported purchasing 9,000 shares of Stark Novus Financial Inc. Common Stock at $1.83 per share on August 25, 2026, in an open-market or private transaction.
Was the NRDE insider trade made under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote indicating that the 9,000-share purchase of NRDE stock was made pursuant to a Rule 10b5-1 trading plan.
Who is identified in connection with the NRDE reporting person on this Form 4?
The reporting person is ESOPUS CREEK VALUE SERIES FUND LP - SERIES A, a director of Stark Novus Financial Inc. The remarks state that Andrew L. Sole can determine investment and voting decisions but disclaims beneficial ownership except for his pecuniary interest.
AI-generated analysis. How Rhea-AI works. Not financial advice.